FDA Orange Book

Is there a generic for Veozah?

Veozah contains fezolinetant. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Veozah (fezolinetant). The Orange Book shows its last listed patent expires March 28, 2034 and its last listed exclusivity ends May 12, 2028.

Run it in Rivvi

Map Veozah and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Veozah products in the Orange Book

Veozah products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oral45MGMarketed (Rx)None0None

NDA 216578, held by ASTELLAS PHARMA US INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Veozah patents

Patents listed for Veozah
PatentExpiresCoversUse codeNDA
8871761April 4, 2031Drug substanceNone216578
10836768March 28, 2034Method of useU-3622216578
9987274March 28, 2034Method of useU-3622216578
9422299March 28, 2034Drug substance, Drug productU-3622216578

Veozah exclusivity

Exclusivity listed for Veozah
CodeMeaningExpiresNDA
NCENew chemical entityMay 12, 2028216578

Veozah NDC codes

Questions

Is there a generic for Veozah?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Veozah (fezolinetant). The Orange Book shows its last listed patent expires March 28, 2034 and its last listed exclusivity ends May 12, 2028.

What is the generic name for Veozah?

The active ingredient in Veozah is fezolinetant, per the FDA Orange Book.

When does the Veozah patent expire?

The last patent listed for Veozah in the Orange Book expires March 28, 2034. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Veozah and Fezolinetant

Try it on your own data today.

Free to start. Most teams are using it the same day.